These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 15563295)

  • 1. Expert and public perception of risk from biotechnology.
    Savadori L; Savio S; Nicotra E; Rumiati R; Finucane M; Slovic P
    Risk Anal; 2004 Oct; 24(5):1289-99. PubMed ID: 15563295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laypeople's and experts' perception of nanotechnology hazards.
    Siegrist M; Keller C; Kastenholz H; Frey S; Wiek A
    Risk Anal; 2007 Feb; 27(1):59-69. PubMed ID: 17362400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM foods and the misperception of risk perception.
    Gaskell G; Allum N; Wagner W; Kronberger N; Torgersen H; Hampel J; Bardes J
    Risk Anal; 2004 Feb; 24(1):185-94. PubMed ID: 15028010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lay and expert perceptions of zoonotic risks: understanding conflicting perspectives in the light of moral theory.
    Jensen KK; Lassen J; Robinson P; Sandøe P
    Int J Food Microbiol; 2005 Apr; 99(3):245-55. PubMed ID: 15808359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceived risks and perceived benefits of different nanotechnology foods and nanotechnology food packaging.
    Siegrist M; Stampfli N; Kastenholz H; Keller C
    Appetite; 2008 Sep; 51(2):283-90. PubMed ID: 18406006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactions to genetically modified food crops and how perception of risks and benefits influences consumers' information gathering.
    Wilson C; Evans G; Leppard P; Syrette J
    Risk Anal; 2004 Oct; 24(5):1311-21. PubMed ID: 15563297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes of the public and scientists to biotechnology in Japan at the start of 2000.
    Ng MA; Takeda C; Watanabe T; Macer D
    Eubios J Asian Int Bioeth; 2000 Jul; 10(4):106-13. PubMed ID: 16273712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial and cultural factors affecting the perceived risk of genetically modified food: an overview of the literature.
    Finucane ML; Holup JL
    Soc Sci Med; 2005 Apr; 60(7):1603-12. PubMed ID: 15652691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese public understanding of the use of agricultural biotechnology--a case study from Zhejiang Province of China.
    Lü L
    J Zhejiang Univ Sci B; 2006 Apr; 7(4):257-66. PubMed ID: 16532526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An empirical test of competing theories of hazard-related trust: the case of GM food.
    Allum N
    Risk Anal; 2007 Aug; 27(4):935-46. PubMed ID: 17958502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who does the public trust? The case of genetically modified food in the United States.
    Lang JT; Hallman WK
    Risk Anal; 2005 Oct; 25(5):1241-52. PubMed ID: 16297228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public perceptions of transgenic animals.
    Einsiedel EF
    Rev Sci Tech; 2005 Apr; 24(1):149-57. PubMed ID: 16110885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hazard perception, risk perception, and the need for decontamination by residents exposed to soil pollution: the role of sustainability and the limits of expert knowledge.
    Vandermoere F
    Risk Anal; 2008 Apr; 28(2):387-98. PubMed ID: 18419656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transparent communication strategy on GMOs: will it change public opinion?
    Sinemus K; Egelhofer M
    Biotechnol J; 2007 Sep; 2(9):1141-6. PubMed ID: 17703492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gap between science and perception: the case of plant biotechnology in Europe.
    Einsele A
    Adv Biochem Eng Biotechnol; 2007; 107():1-11. PubMed ID: 17522817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional study of biotechnology awareness and teaching in European high schools.
    Vanderschuren H; Heinzmann D; Faso C; Stupak M; Arga KY; Hoerzer H; Laizet Y; Leduchowska P; Silva N; Simková K
    N Biotechnol; 2010 Dec; 27(6):822-8. PubMed ID: 20178865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceiving others' perceptions of risk: still a task for Sisyphus.
    Finkel AM
    Ann N Y Acad Sci; 2008 Apr; 1128():121-37. PubMed ID: 18469220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge, attitudes towards and acceptability of genetic modification in Germany.
    Christoph IB; Bruhn M; Roosen J
    Appetite; 2008 Jul; 51(1):58-68. PubMed ID: 18243411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and biomedical aspects of genetically modified food.
    Celec P; Kukucková M; Renczésová V; Natarajan S; Pálffy R; Gardlík R; Hodosy J; Behuliak M; Vlková B; Minárik G; Szemes T; Stuchlík S; Turna J
    Biomed Pharmacother; 2005 Dec; 59(10):531-40. PubMed ID: 16298508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bringing scientists to the people--the Co-Extra website.
    Breyer D; Daubresse P; Sneyers M
    Biotechnol J; 2007 Sep; 2(9):1081-5. PubMed ID: 17703490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.